Startup Deep Dive : RAS Luxury Oils — a farm-to-face beauty brand now funded by the FMCG giants it set out to shame

RAS Luxury Oils built its entire pitch on a single accusation: that most of India’s “natural” skincare brands lie about what is actually inside the bottle. Genuine rose oil costs roughly Rs 12-14 lakh a litre to distil, the company’s founders have argued, so a mass-market bottle claiming pure rose oil at a fraction of that cost almost certainly is not what it says (The Established, 2022). That argument has since pulled in Rs 53.2 crore (~$5.5 million) of FY25 revenue, up 58 percent on FY24 (Inc42; Tracxn, as of March 2026), and three rounds of venture money from exactly the kind of large consumer companies whose supply chains the brand set out to shame.

The contradiction sits in the cap table. A business that began in 2017 as a mother-and-daughter project distilling essential oils on farms around Raipur, Chhattisgarh, is today backed by Unilever Ventures — the venture arm of a company that owns dozens of the mass-market beauty brands RAS’s founding story implicitly criticises — and, since March 2026, by Dabur Ventures, the investment arm of one of India’s oldest Ayurveda-to-FMCG conglomerates (Entrepreneur India; WWD, March 2026). How a hyper-local “farm-to-face” story ended up funded by the industry it set out to disrupt is most of what follows.

Quick facts

What they do

RAS Luxury Oils is a Mumbai-headquartered, Raipur-rooted D2C beauty company that makes and sells “farm-to-face” essential oils, facial elixirs, serums and creams, positioned at the premium end of India’s natural and Ayurveda-inspired skincare market. The company says it controls its supply chain end to end — from cultivating or sourcing aromatic plants, through in-house steam distillation and DSIR-approved formulation labs, to bottling and packaging — which it uses to justify claims of purity that cheaper “natural” brands, in its telling, cannot back up (StartupTalky; Inc42, “How RAS Luxury Skincare Is Making Ayurveda-Backed Clean Beauty Mainstream”). Its customers span online shoppers buying anti-ageing and brightening serums through the brand’s own site and marketplaces, and five-star hotels and spas that use its oils in guest amenities and spa treatments.

The origin

The company’s founding insight came from Shubhika Jain noticing a gap between what luxury skincare brands claimed on their labels and what was economically possible in their bottles. Authentic rose oil, she has said, costs somewhere around Rs 12-14 lakh a litre to produce — which means most affordable “rose oil” products on Indian shelves cannot contain what they advertise (The Established, 2022). Jain came from a fourth-generation trading family in Raipur whose earlier businesses included rice mills and extraction units, and whose father had moved into agri-biotech and education; she herself studied at Lady Shri Ram College in Delhi and briefly worked at a management consultancy before returning to the family business. In 2017, she and her mother, Sangeeta Jain, turned a household habit — skincare made from handpicked flowers and herbs grown in their own garden — into a commercial venture, positioning it as India’s first “farm-to-face” beauty brand (StartupTalky; The Established).

The struggle years

The early years were not smooth. Jain has spoken about resistance from existing staff who were reluctant to accept a young woman — she was in her early twenties at launch — as their head, resistance she says she overcame only by demonstrating consistent, strategic execution over time (StartupTalky). Building the supply side of a “farm-to-face” model from scratch meant visiting farmer fields directly, securing government certifications, and working through legal and regulatory documentation with almost no playbook to follow, since no Indian brand had built quite this model before (StartupTalky).

The bigger, dated setback came from a channel bet. In its first years, RAS built its business mainly by supplying five-star hotels and spa chains — properties associated with brands such as St Regis, Four Seasons, Park Hyatt and Shangri-La — alongside a smaller consumer retail push (StartupTalky). That wholesale, footfall-dependent hospitality channel was structurally fragile, and it was exposed in full when India’s COVID-19 lockdowns began in March 2020 and hotel occupancy collapsed nationwide. With its primary sales channel effectively switched off overnight, the company had to re-found its go-to-market almost from zero, refocusing entirely on e-commerce at a moment when it had little online infrastructure or brand recognition to draw on (The Established, 2022).

The turning point

The turning point was that enforced pivot. Before 2020, RAS was a hospitality-supply business with a side hustle in consumer retail — a model with revenue tied to how many rooms Indian luxury hotels could fill. After 2020, it rebuilt itself as an e-commerce-first D2C skincare brand, selling directly to consumers through its own website and marketplaces rather than through hotel purchasing departments. The shift compounded fast: by 2022, press coverage of the company described “20x growth in the last two years” on the back of the e-commerce move (Indian Retailer; Marketing Mind, 2022). That growth curve is also what made RAS fundable — its first institutional cheques followed almost immediately, with a seed round around 2021 and a pre-Series A round in May 2022, both arriving once the company could show a repeatable online growth engine rather than a hospitality order book (Tracxn; BeautyMatter).

The money behind it

RAS has raised capital in stages, moving from a specialist consumer-focused early investor to two of the largest strategic names in Indian and global FMCG:

• Seed, around September 2021: early institutional capital including Green Frontier Capital, alongside continued backing from Sixth Sense Ventures (Tracxn; Green Frontier Capital portfolio page). Amount not fully disclosed.
• Pre-Series A, May 2022: $2 million (~Rs 15 crore at the time) led by Sixth Sense Ventures, a consumer-and-retail-focused Indian VC — capital that funded the inventory and team build-out needed to keep scaling the post-COVID e-commerce channel (BeautyMatter; Indian Startup News).
• Series A, 11 September 2024: $5 million (reported as roughly Rs 42 crore at the time), led by Unilever Ventures, with Amazon Smbhav Venture Fund and Sixth Sense Ventures also participating. RAS was selected for Unilever’s FAST42 beauty-and-personal-care accelerator programme ahead of the round, which brought a global beauty conglomerate’s R&D and category credibility alongside the cheque (YourStory; Global Cosmetics News; Inc42).
• Angel round, June 2025: an additional, undisclosed-amount angel tranche recorded by Tracxn.
• Series B, 2-3 March 2026: $7.5 million (~Rs 72 crore) led by Dabur Ventures — the investment arm of Dabur India — with Unilever Ventures increasing its stake and Amazon Smbhav Venture Fund and Sixth Sense Ventures also participating. Dabur’s involvement was widely read as a legacy Ayurveda-FMCG player endorsing the “clean, ingredient-led” premium skincare thesis that upstarts like RAS represent (Entrepreneur India; WWD; Business Review Live; Inc42).

Total disclosed funding across these four announced rounds comes to roughly $16 million as of March 2026, per Inc42’s company tracker; other trackers such as Tracxn ($17.7 million across eight tranches, including smaller undisclosed rounds) and Entrackr’s running tally (implying around $19.5 million) put the cumulative figure somewhat higher, reflecting rounds whose exact size was never made public. RAS has not disclosed a valuation for any round, including the March 2026 Series B, and no valuation figure in circulation could be corroborated against a second independent source, so none is stated here.

How it makes money

RAS earns money by selling its own branded skincare and essential-oil products at premium price points across several channels simultaneously, rather than relying on one route to the customer. Its stated model is vertical integration — owning the plant sourcing, extraction, formulation, bottling and packaging in-house — which it uses both as a cost-and-quality control lever and as the core of its marketing claim that its “purity” cannot be faked by copycats (Inc42; StartupTalky).

• Direct-to-consumer: its own website, rasluxuryoils.com, selling full-margin, first-party data-generating orders.
• E-commerce marketplaces: Amazon, Nykaa, Flipkart, Tata CliQ, FirstCry and Tira (Inc42).
• Quick commerce: Blinkit, Zepto and Swiggy Instamart, added as those platforms became meaningful beauty-sales channels in India (Inc42).
• Offline retail: exclusive brand outlets (EBOs) and shop-in-shop counters, including a flagship store at Nexus Seawoods in Navi Mumbai, with further EBOs planned using Series B proceeds (Indian Retailer; Business Review Live).
• HORECA / hospitality: supply to hotel and spa groups including the Oberoi Group and Fairmont, a return to the channel that nearly broke the company in 2020, now run alongside — not instead of — e-commerce (Inc42).

The part outsiders tend to get wrong is treating RAS as a niche “essential oils” bootstrap brand frozen at its 2017 origin story. In practice it has broadened into a wider skincare and personal-care house — its corporate entity, RAS Beauty Private Limited, also houses a second brand, Moody, per Tracxn’s filings data — and it is no longer family-funded: more than $16 million of institutional and strategic capital now sits in its cap table, most of it from the same large-FMCG orbit its founding pitch positioned itself against.

The numbers

RAS does not publish audited results publicly; the figures below come from filings-based reporting by business trackers and are the only two fiscal years for which an absolute revenue number could be independently corroborated across more than one source.

• FY24 revenue: Rs 33.7 crore, up 136% year-on-year (Inc42 company tracker; Inc42 feature on RAS’s business model).
• FY25 revenue: Rs 53.2 crore, up 58.0% year-on-year (Inc42; corroborated by Tracxn’s RAS Beauty Private Limited filing summary).
• Run-rate context: reported annual recurring revenue of roughly Rs 100 crore as of the March 2026 Series B (Entrackr; Business Review Live) is broadly in the same range as CB Insights’ independent FY2026 revenue estimate of $10.98 million (~Rs 105 crore) — two different sources pointing to a similar current scale, though neither is an audited figure.
• Profit or loss: not disclosed by the company in any source reviewed. For context on what fast-growing Indian D2C beauty brands often look like at this stage, competitor Sugar Cosmetics reported Rs 505 crore revenue against a Rs 76 crore loss in FY24, and mCaffeine’s revenue declined to Rs 193 crore the same year (Entrackr) — RAS’s own bottom line could not be confirmed either way, so it is reported here as undisclosed rather than estimated.

Where the money comes from

• Channel spread: revenue is split across the brand’s own D2C site, mainstream e-commerce marketplaces, quick commerce apps, offline EBOs/shop-in-shops, and HORECA hotel-and-spa supply (Inc42) — no single channel’s exact percentage share has been disclosed.
• Customer base: more than 5 lakh (500,000) unique customers as of the March 2026 Series B announcement (Business Review Live).
• Geography: operations and retail expansion are concentrated in India’s metropolitan centres, with Series B capital earmarked specifically for new EBOs “in metropolitan centres” (Business Review Live); no material international revenue has been reported.
• The surprise: the hospitality channel that nearly ended the company in the COVID-19 lockdowns of 2020 is back as a live growth line today, with the brand supplying groups such as the Oberoi Group and Fairmont (Inc42) — the same channel that once represented existential concentration risk is now presented as diversification.

The risks

• Undisclosed profitability at a stage where peers are burning heavily: RAS has not published profit-or-loss figures for any year, even as it raises larger rounds. Comparable Indian D2C beauty peers have posted significant losses at similar revenue scale — Sugar Cosmetics lost Rs 76 crore on Rs 505 crore of FY24 revenue (Entrackr) — so investors and readers are being asked to take RAS’s unit economics on faith rather than on disclosed numbers.
• A crowded, well-capitalised premium-natural segment: RAS competes directly with Forest Essentials (majority-owned by Wipro Consumer Care) and Kama Ayurveda (majority stake sold to Spain’s Puig in 2023), both of which now sit inside deep-pocketed conglomerates, as well as mass-premium challengers such as Minimalist and Plum and FMCG incumbents Hindustan Unilever and Marico (ucapital.com analysis of the Series B round). Two of RAS’s own investors — Unilever and Dabur — separately compete in adjacent parts of the same beauty-and-personal-care market through their own brand portfolios.
• Multi-round dilution and reliance on strategic FMCG capital: RAS has taken four announced institutional rounds in under five years, moving from specialist consumer VCs to strategic corporate-venture arms of Unilever and Dabur. Strategic investors can bring distribution and credibility, but they can also have their own category interests, and repeated dilution raises the execution bar for the founding family, which Tracxn still shows as the largest single shareholder block.

The takeaway

The lesson in RAS Luxury Oils’s story is not really about essential oils or about honesty in ingredient labelling, even though that is the story the founders tell. It is about channel risk. The company’s near-death moment in 2020 did not come from a bad formulation, a lawsuit or a fraud allegation — it came from having built its entire early business on a single, footfall-dependent wholesale channel that a pandemic could switch off in a matter of weeks. What saved it was not a better product but a forced reallocation to the one channel — e-commerce — whose demand did not depend on other people’s buildings staying open. Once that channel proved it could scale, the capital followed, first from specialist consumer investors and eventually from the exact large FMCG groups the brand’s founding story was originally pitched against. For any founder, the transferable point is the same: diversify how customers can reach you before a crisis forces the question, because the pivot that saves a company is rarely the one it plans for.

Frequently asked questions

Who founded RAS Luxury Oils and when?

RAS Luxury Oils was founded in 2017 in Raipur, Chhattisgarh, by Shubhika Jain along with her mother, Sangeeta Jain, and sister, Suramya Jain. Its corporate entity, RAS Beauty Private Limited, was incorporated on 19 April 2021 (StartupTalky; TheCompanyCheck).

How much funding has RAS Luxury Oils raised?

Roughly $16 million across four announced institutional rounds as of March 2026 — a seed round, a $2 million pre-Series A in May 2022, a $5 million Series A in September 2024 led by Unilever Ventures, and a $7.5 million Series B in March 2026 led by Dabur Ventures (Inc42; Entrepreneur India). Other trackers place the cumulative total slightly higher due to undisclosed smaller tranches.

What is RAS Luxury Oils’s revenue?

Rs 53.2 crore in FY25 (year ended 31 March 2025), up 58.0% from Rs 33.7 crore in FY24 (Inc42; Tracxn). The company has separately cited an annual recurring revenue run rate of around Rs 100 crore as of its March 2026 Series B.

Is RAS Luxury Oils profitable?

The company has not publicly disclosed profit-or-loss figures for any fiscal year, so its profitability status cannot be independently confirmed either way.

What happened to RAS Luxury Oils during COVID-19?

Before 2020, the company relied heavily on supplying five-star hotels and spas. India’s COVID-19 lockdowns collapsed that hospitality channel, forcing an emergency pivot to e-commerce and direct-to-consumer sales — a shift that the company credits with the roughly 20x growth it reported over the following two years (The Established; Indian Retailer).

Sources

Figures are as of September 2026. Currency converted at $1 ≈ ₹96.0 as of 18 September 2026 (Trading Economics).

• Inc42, company tracker, “RAS Luxury Oils — Funding & Revenue” (accessed September 2026)
• Inc42, “How RAS Luxury Skincare Is Making Ayurveda-Backed Clean Beauty Mainstream” (2026)
• Inc42, “RAS Luxury Raises $7.5 Mn From Dabur Ventures, Unilever Ventures” (March 2026)
• The Established, “Shubhika Jain and the secret behind building RAS Luxury Oils as a successful farm-to-face brand” (2022)
• BeautyMatter, “Luxury Indian Start-Up Ras Luxury Oils Raises $2 Million” (May 2022)
• Indian Startup News, “Luxury skincare brand RAS Luxury Oils raises $2M in a pre-Series A round led by Sixth Sense Ventures” (2022)
• YourStory, “RAS Luxury secures $5M from Unilever Ventures to fuel…” (January 2025)
• Global Cosmetics News, “Ras Luxury Skincare raises US$5 million in Series A funding led by Unilever Ventures” (2025)
• Entrepreneur India, “RAS Luxury Skincare Secures USD 7.5 Mn in Series B Funding Led by Dabur Ventures” (March 2026)
• WWD, “RAS Luxury Skincare Closes $7.5 Million Series B Funding Round” (March 2026)
• Business Review Live, “Premium beauty brand RAS Luxury Skincare raises $7.5 Mn to strengthen luxury skincare presence across India” (March 2026)
• Entrackr, “RAS Luxury Skincare raises $7.5 Mn in Series B led by Dabur Ventures” (March 2026)
• Entrackr, “Sugar Cosmetics reports Rs 505 Cr revenue and Rs 76 Cr loss in FY24”; “mCaffeine’s revenue declines to Rs 193 Cr in FY24” (used for peer context only)
• ucapital.com, “How RAS Luxury Skincare’s $7.5M Series B funding round signals a new era for Indian D2C beauty brands” (March 2026)
• StartupTalky, “RAS Luxury Oils – India’s first ‘Farm-to-Face’ beauty startup” (accessed September 2026)
• Indian Retailer, “How RAS Luxury Oils is Growing 20x from Past Two Years?” and “RAS Luxury Skincare Expands with Flagship Store at Nexus Seawoods in Navi Mumbai” (2022; 2026)
• Marketing Mind, “How Ras Luxury Oils Grew 20x In Just Two Years” (2022)
• Tracxn, “RAS Luxury Oils” company and funding profile (accessed March 2026)
• TheCompanyCheck, “Ras Beauty Private Limited” MCA-sourced company profile (accessed September 2026)
• CB Insights, “RAS Luxury Skincare” financials profile (accessed September 2026)
• Green Frontier Capital, “RAS Luxury Oils” portfolio page (accessed September 2026)

Found an error? Write to us and we’ll correct it in the open, dated, on the piece.